MIF and metabolic syndrome: As hs-CRP is an inflammatory marker, we also compared its levels in the same way as MIF, and there were no statistical differences between STEMI patients with or without MACCE in overall STEMI patients and STEMI patients with or without MetS (Supplementary Figure 1).